The world pharmaceutical market was worth an estimated $1.2 trillion at ex-factory prices in 2020. It is one of the top performing industries globally. New medications are constantly being developed, approved and marketed, resulting in significant market growth. The FDA approved 55 novel drugs in 2021. Other market growth drivers include the aging population, as seniors use more medicines per capita and there is a rise in the prevalence and treatment of chronic diseases. Immunology, oncology and neurology are the fastest-growing therapy areas and are expected to be the main sources of growth through 2026. The biologics market is growing at significant rate and is expected to continue outstripping that of small molecules in the coming decade. The three largest biologic therapy areas include oncology, autoimmune and diabetes.
The U.S. dominates the global pharmaceutical markets, accounting for almost half of pharmaceutical sales globally in 2021. However, the industry faces many challenges including regulatory hurdles, escalating R&D costs, and competition from generic drugs and biosimilars. The pharmaceutical industry, one of the most profitable industries in the world, is under significant pressure to bring in cost-effective and innovative drugs. The discipline of precision medicine and genomic medicine has gained significant interest from researchers and healthcare providers globally. Already, it is making an impact in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease, and its popularity is expected to grow significantly in coming years. Sensing the huge opportunity in the field of precision medicine and genomic medicine, several big pharma companies have been making huge investments to expand their precision and genomic medicine portfolios and pipelines. The number of personalized drugs is expected to double or even triple in the upcoming years.
The U.S. dominates the global pharmaceutical markets, accounting for almost half of pharmaceutical sales globally in 2021. However, the industry faces many challenges including regulatory hurdles, escalating R&D costs, and competition from generic drugs and biosimilars. The pharmaceutical industry, one of the most profitable industries in the world, is under significant pressure to bring in cost-effective and innovative drugs. The discipline of precision medicine and genomic medicine has gained significant interest from researchers and healthcare providers globally. Already, it is making an impact in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease, and its popularity is expected to grow significantly in coming years. Sensing the huge opportunity in the field of precision medicine and genomic medicine, several big pharma companies have been making huge investments to expand their precision and genomic medicine portfolios and pipelines. The number of personalized drugs is expected to double or even triple in the upcoming years.
Market Forecasts
- The global market for generic drugs should grow from $411.6 billion in 2020 to $650.3 billion by 2025, at a compound annual growth rate (CAGR) of 9.6% for the period of 2020-2025.
- The global market for orphan drugs should grow from $190.8 billion in 2021 to $248.2 billion by 2026, at a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.
- The global market for oncology pharmaceuticals should grow from $177.4 billion in 2021 to $313.7 billion by 2026, at a compound annual growth rate (CAGR) of 12.1% for the period of 2021-2026.
Table of Contents
Chapter 1 Foreword
- Foreword
Chapter 2 Global Markets for Generic Drugs (PHM009J)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources and Methodology
- Geographic Breakdown
- Summary and Highlights
- Market Overview
- Types of Generic Drugs
- The Patent Cliff
- Global Market for Generic Drugs
- Leading Generic Molecules
- Market Shares of Pharmaceutical Drugs by Therapeutic Area
- Market Breakdown by Region
- North America
- Canada
- Asia-Pacific
- Europe
- Rest of the World
- Competitive Landscape
Chapter 3 Global Markets for Orphan Drugs (PHM038F)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources and Methodology
- Geographic Breakdown
- Summary and Highlights
- Definitions and Background
- Types of Orphan Drugs
- Comparison of the Regulation of Rare Diseases and Orphan Drugs Worldwide
- Global Orphan Drug Market Analysis
- By Product Type
- By Region
- By Drug Type
- By Therapeutic Category
- Industry Structure and Current Trends
- Market Dynamics
- Trends in Clinical Trials for Drug Development in Rare Diseases
- Orphan Drug Exclusivity
Chapter 4 Global Oncology Pharmaceutical Market (PHM256A)
- Introduction
- Study Goals and Objectives
- Scope of Report
- Methodology and Information Sources
- Geographic Breakdown
- Summary and Highlights
- Market Breakdown by Drug Type
- Overview
- Immunotherapy
- Global Market Revenue
- Targeted Therapy
- Immunotherapy
- Market Breakdown by Application
- Overview
- Market Revenue
- Market Breakdown, by Region
- North American Market for Oncology Pharmaceuticals, by Type
- European Market for Oncology Pharmaceuticals, by Type
- Asia Pacific Market for Oncology Pharmaceuticals, by Type
- RoW Market for Oncology Pharmaceuticals, by Type
- Competitive Landscape
- Impact of COVID-19 Pandemic
Chapter 5 Immunotherapy Drugs: Global Markets (PHM249A)
- Introduction
- Study Goals and Objectives
- Scope of Report
- Methodology
- Information Sources
- Geographic Breakdown
- Summary and Highlights
- Immunotherapy
- Types of Immunotherapies
- Checkpoint Inhibitors
- Immunotherapy against Autoimmune Disorders
- Market Breakdown by Product Type
- Monoclonal Antibodies
- Checkpoint Inhibitors
- Interferons and Interleukins
- SWOT Analysis of Immunotherapy Market
Chapter 6 Global Markets for Infectious Disease Treatments (PHM061E)
- Introduction
- Study Goals and Objectives
- Reasons for Doing this Study
- Scope of Report
- Information Sources and Methodology
- Geographic Breakdown
- Summary and Highlights
- Overview
- Global Market for Infectious Disease Treatments by Region
- Global Market for Infectious Disease Treatments by Segment
- Global Market for Infectious Disease Therapeutics by Disease Type
- Global Market for Infectious Disease Vaccines by Disease Type
- Global Market for Infectious Disease Diagnostics by Disease Type
- Global Infectious Diseases
- Hepatitis B and Hepatitis C
- Herpes Simplex Virus
- HIV/AIDS
- Influenza - A and B
- Rotavirus
- Respiratory Syncytial Virus
- Malaria
- Tuberculosis
- MERS-CoV
- Viral Hemorrhagic Fevers
Chapter 7 harmaceutical Treatments for Mental Health Disorders: Global Markets (PHM237A)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources and Methodology
- Geographic Breakdown
- Analyst’s Credentials
- Summary and Highlights
- Attention Deficit Hyperactivity Disorder
- Segmentation by Geography
- Segmentation by Drug Class
- Segmentation by Company
- Current Treatments
- Depression and Anxiety
- Segmentation by Drug Class
- Segmentation by Company
- Current Treatments
- Substance Use Disorders
- Segmentation by Geography
- Segmentation by Drug Class
- Segmentation by Company
- Current Treatments
- Schizophrenia
- Segmentation by Geography
- Segmentation by Drug Class
- Segmentation by Company
- Current Treatments
Chapter 8 Excipients in Pharmaceuticals: Global Markets to 2026 (PHM010L)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources and Methodology
- Geographic Breakdown
- Analyst's Credentials
- Summary and Highlights
- Summary
- Highlights
- Excipient in Pharmaceuticals - Definition
- Pharmaceutical Excipients Global Market Size and Forecast
- Market Dynamics
- Pharmaceutical Excipients Market by Material
- Organic Excipients-Types & Market Analysis
- Carbohydrates
- Oleochemicals
- Petrochemical-based Excipients
- Protein
- Other Organic Excipients
- Inorganic Excipients
- USP Water
- Pharmaceutical Excipients Market by Dosage Forms
- Solid Forms
- Semisolid Dosage Forms
- Liquid Dosage Forms
- Other Dosage Forms
- Pharmaceutical Excipients Market by Route of Administration
- Oral
- Topical
- Injectables
- Advanced Drug Delivery Methods and Other Routes of Administration
- Excipients for Pharmaceuticals Market by End Users
- Pharmaceutical Companies
- Contract Formulators
- Research Institutes
- Other End Users
- Excipients for Pharmaceuticals Market by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
- Supplier Landscape
- Patent Review for Pharmaceutical Excipients Market
Chapter 9 Softgel Capsules:Global Markets (PHM244A)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources and Methodology
- Geographic Breakdown
- Summary and Highlights
- Overview of Softgel Capsules
- Market Breakdown by Type
- Gelatin Capsules
- Vegetarian Capsules
- Market Breakdown by Application
- Health Supplements
- Vitamins and Dietary Supplements
- Others
- Market Breakdown by End User
- Pharmaceutical and Nutraceutical Companies
- Contract Manufacturing Companies
- Others
- Market Breakdown by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
- Competitive Landscape
- Porter’s Five Forces Analysis
Chapter 10 Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging (PHM043H)
- Introduction
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Summary and Highlights
- Summary
- Key Highlights
- Contract Manufacturing
- Contract Manufacturing Services
- Contract Manufacturing of Bulk Drugs and Active Pharmaceutical Ingredients
- Contract Manufacturing of Dosage Forms
- Contract Manufacturing of Advanced Drug Delivery Products
- Contract Manufacturing of Over-the-Counter and Nutritional Products
- Contract Research Services
- Market by Discipline
- Market by Region
- Contract Packaging Services
- Market Breakdown by Application
- Contract Manufacturing by Application and Therapeutics
- Contract Research by Application and Therapeutic Area
- Competitive Landscape
- Contract Manufacturing
- Contract Research
- Contract Packaging
Chapter 11 Pharma 4.0 Market (PHM248A)
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Pharma 4.0: Technology Background
- Key Technologies in Pharma 4.0 Artificial Intelligence (AI) in Pharma
- Types of Artificial Intelligence
- Application of Artificial Intelligence in Pharma
- Pharma Companies Using AI Platform
- 3D Printing in Pharma
- Types of 3D Printing Technology
- 3D Printing Technology in Pharmaceuticals
- Pharma Players Using 3D Printing Technology
- Advantages of 3D Printing Technology in Pharmaceuticals
- Industrial Robotics in Pharma
- Application of Robots in the Pharma Industry
- Commonly Used Robots in the Pharmaceutical Industry
- Augmented and Virtual Reality in the Pharma Industry
- Applications of Augmented Reality and Virtual Reality in the Pharma Industry
- Internet of Things (IoT) in the Pharma Industry
- IoT in Healthcare
- Application of IoT in Pharma
- Blockchain Technology in the Pharma Industry
- Application of Blockchain in Pharma
Chapter 12 Neurostimulation: Technologies and Global Markets (PHM149B)
- Introduction
- Study Goals and Objectives
- Scope of This Report
- Methodology and Information Sources
- Geographic Breakdown
- Summary and Highlights
- Introduction to Neurostimulation
- Types of Neurostimulation Technologies
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation (SNS)
- Vagus Nerve Stimulation
- Hypoglossal Nerve Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation (TMS)
- Others
- Global Market for Neurostimulation Devices, by Device Type
- Spinal Cord Stimulation (SCS) Devices
- Deep Brain Stimulation (DBS) Devices
- Sacral Nerve Stimulation (SNS) Devices
- Vagus Nerve Stimulation (VNS) Devices
- Hypoglossal Nerve Stimulation (HGNS) Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- Transcranial Magnetic Stimulation (TMS) Devices
- Other Neurostimulation Devices
- Market Breakdown by Therapeutic Application
- Chronic Pain
- Urinary and Fecal Incontinence
- Parkinson’s Disease
- Epilepsy
- Obstructive Sleep Apnea (OSA)
- Essential Tremor
- Major Depressive Disorder (MDD)/Clinical Depression
- Obsessive Compulsive Disorder (OCD)
- Others
- Market Breakdown by Region
- North America
- Europe
- Asia-Pacific
- RoW
- Competitive Landscape
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Vagus Nerve Stimulation Devices
- Hypoglossal Nerve Stimulation Devices
- Transcranial Magnetic Stimulation Devices
- Transcutaneous Electrical Nerve Stimulation Devices
- Impact of COVID-19
List of Tables
Table 1 : Global Market for Generic Drugs, by Region, Through 2025
Table 2 : Major Recent and Upcoming Patent Expiries, 2016-2021
Table 3 : Sales of Brand Name Drugs Before and After Patent Expiry
Table 4 : Biologics with Recent or Upcoming Loss of Patent Protection
Table 5 : Global Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 6 : Global Market for Generic Drugs Compared with the Total Pharmaceutical Market, by Region, Through 2025
Table 7 : Global Market for Generic Drugs, by Top 10 Countries, Through 2025
Table 8 : Top 20 Generic Molecules, 2019
Table 9 : Global Top Selling Pharmaceuticals, 2019
Table 10 : Global Market for Generic Drugs, by Region, Through 2025
Table 11 : U.S. Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 12 : Canadian Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 13 : Chinese Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 14 : Japanese Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 15 : Japanese Pharmaceutical Sales, by Top 25 Japanese Pharma Companies, 2018 and 2019
Table 16 : Indian Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 17 : Leading Generic Drug Companies in India
Table 18 : Rest of Asia-Pacific Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 19 : German Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 20 : French Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 21 : Italian Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 22 : U.K. Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 23 : Spanish Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 24 : Penetration of Generic Drugs in the Pharmaceutical Market in the Rest of Europe, by Country, 2019
Table 25 : Rest of European Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 26 : Rest of the World Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 27 : Leading Generic Drug Companies, by Sales, 2019
Table 28 : ANDA Approvals of Generic Drugs, by Company, 2019(Number)
Table 29 : Global Market for Orphan Drugs, by Product Type, Through 2026
Table 30 : Prevalence of Rare Diseases
Table 31 : Comparison of the Regulation of Rare Diseases and Orphan Drugs Worldwide
Table 32 : Global Market for Orphan Drugs, by Product Type, Through 2026
Table 33 : Growth in Orphan Designations, by Region/Country, 2010-2020
Table 34 : Global Market for Orphan Drugs, by Region, Through 2026
Table 35 : Global Orphan Drug Sales, by Drug Type, Through 2026
Table 36 : Global Orphan Drug Sales, by Therapeutic Category, Through 2026
Table 37 : Market Shares of Top 20 Companies, 2020
Table 38 : Characteristics of the NCT, EUCTR and JPRN Trials
Table 39 : Number of Trials in NCT, EUCTR and JPRN Trials, by Phase
Table 40 : Number of Trials in NCT, EUCTR and JPRN Trials, by Country
Table 41 : Top 20 Most Studied Rare Diseases, by Number of Trials
Table 42 : Top 20 Most Studied Drugs for Rare Diseases, by Number of Diseases
Table 43 : Orphan Drug Approvals and Exclusivity, 2020
Table 44 : Global Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 45 : Cancer Drug Treatment Classes
Table 46 : Global Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 47 : Global Market for Targeted Therapy Pharmaceuticals, by Type, Through 2026
Table 48 : Global Market for Immunotherapy Pharmaceuticals, by Type, Through 2026
Table 49 : Global Market for Oncology Pharmaceuticals, by Cancer Type, Through 2026
Table 50 : Global Market for Oncology Pharmaceuticals, by Region, Through 2026
Table 51 : North American Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 52 : European Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 53 : Asia-Pacific Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 54 : RoW Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 55 : Leading Oncology Pharmaceuticals Company's Market Share, 2020
Table 56 : Blockbuster Oncology Pharmaceuticals, 2020
Table 57 : Selected Blockbuster Oncology Pharmaceuticals, by Company, 2020
Table 58 : Global Market for Immunotherapy Drugs, by Product Type, Through 2025
Table 59 : Advantages and Disadvantages of Monoclonal Antibodies
Table 60 : Selected Approved Interferon Alpha Analogs
Table 61 : Biologics as Autoimmune Disorder Therapies
Table 62 : Global Market for Immunotherapy Drugs, by Product Type, Through 2025
Table 63 : Global Market for Monoclonal Antibodies, by Type, Through 2025
Table 64 : Global Market Shares for Monoclonal Antibody Drugs, by Type, 2019
Table 65 : Global Market for Monoclonal Antibody Drugs, by Region, Through 2025
Table 66 : Global Market for Checkpoint Inhibitors, 2019-2025
Table 67 : Global Market of Checkpoint Inhibitors, by Region, Through 2025
Table 68 : Global Market for Interferons and Interleukins, Through 2025
Table 69 : Global Market for Interferons and Interleukins, by Region, Through 2025
Table 70 : Global Market for Infectious Disease Treatments, by Segment, Through 2026
Table 71 : Leading Causes of Death Due to Infectious Diseases, by Region, 2019
Table 72 : Global Market for Infectious Disease Treatment, by Region, Through 2026
Table 73 : Global Market for Infectious Disease Treatments, by Segment, Through 2026
Table 74 : Global Market for Infectious Disease Therapeutics, by Disease Type, Through 2026
Table 75 : Global Market for Infectious Disease Vaccines, by Disease Type, Through 2026
Table 76 : Global Market for Infectious Disease Diagnostics, by Disease Type, Through 2026
Table 77 : Global Market for Hepatitis B Therapeutics, by Region, Through 2026
Table 78 : Global Market for Hepatitis B Vaccines, by Region, Through 2026
Table 79 : Global Market for Hepatitis B Diagnostics, by Region, Through 2026
Table 80 : Global Market for Hepatitis C Therapeutics, by Region, Through 2026
Table 81 : Global Market for Hepatitis C Diagnostics, by Region, Through 2026
Table 82 : Global Market for HSV Therapeutics, by Region, Through 2026
Table 83 : Global Market for HSV Diagnostics, by Region, Through 2026
Table 84 : Global Market for HIV Therapeutics, by Region, Through 2026
Table 85 : Global Market for HIV Diagnostics, by Region, Through 2026
Table 86 : Global Market for Influenza Vaccines, by Region, Through 2026
Table 87 : Global Market for Influenza Diagnostics, by Region, Through 2026
Table 88 : Global Market for Rotavirus Vaccines, by Region, Through 2026
Table 89 : Global Market for Rotavirus Diagnostics, by Region, Through 2026
Table 90 : Global Market for RSV Vaccines, by Region, Through 2026
Table 91 : Global Market for RSV Diagnostics, by Region, Through 2026
Table 92 : Global Market for Malaria Therapeutics, by Region, Through 2026
Table 93 : Global Market for Malaria Vaccines, by Region, Through 2026
Table 94 : Global Market for Malaria Diagnostics (RDTs*), by Region, Through 2026
Table 95 : Global Market for Tuberculosis Therapeutics, by Region, Through 2026
Table 96 : Global Market for Tuberculosis Diagnostics, by Region, Through 2026
Table 97 : Global Market for MERS-CoV Vaccines, by Region, Through 2026
Table 98 : Global Market for Lassa Fever Vaccines, by Region, Through 2026
Table 99 : Global Market for Ebola Fever Vaccines, Through 2026
Table 100 : Global Market for Zika Vaccines, by WHO Region, Through 2026
Table 101 : Global Market for Yellow Fever Vaccines, by WHO Region, Through 2026
Table 102 : Global Market for Dengue Vaccines, by Region, Through 2026
Table 103 : Global Market for Drugs Prescribed to Treat Mental Health Disorders, by Type of Disorder, Through 2025
Table 104 : Global Market for Drugs Prescribed to Treat ADHD, Through 2025
Table 105 : Global Market for Drugs Prescribed to Treat ADHD, by Region, Through 2025
Table 106 : Global Market for Leading Brand Name Drugs Prescribed to Treat ADHD, by Drug/Company, Through 2025
Table 107 : Global Market for Drugs Prescribed to Treat ADHD, by Leading Company/Manufacturer, Through 2025
Table 108 : Drug Profiles of Leading Approved ADHD Treatments
Table 109 : ADHD Drug Profiles
Table 110 : Global Market for Drugs Prescribed to Treat Depression and Anxiety, Through 2025
Table 111 : Global Market for Brand Name Drugs Prescribed to Treat Depression and Anxiety, by Leading Drug/Company, Through 2025
Table 112 : Global Market for Drugs Prescribed to Treat Depression and Anxiety, by Leading Company/Manufacturer
Table 113 : Drug Profiles of Leading Approved Antidepressants
Table 114 : Drugs Recommended for the Treatment of Anxiety
Table 115 : Global Market for Drugs Prescribed to Treat Substance Use Disorders, Through 2025
Table 116 : Global Market for Drugs Prescribed to Treat Substance Use Disorders, by Region, Through 2025
Table 117 : Global Market for Leading Brand Name Drugs Prescribed to Treat Substance Use Disorders, by Drug/Company, Through 2025
Table 118 : Global Market for Drugs Prescribed to Treat Substance Use Disorders, by Leading Company, Through 2025
Table 119 : Global Market for Drugs Prescribed to Treat Schizophrenia, Through 2025
Table 120 : Global Market for Drugs Prescribed to Treat Schizophrenia, by Region, Through 2025
Table 121 : Global Market for Leading Brand Name Drugs Prescribed to Treat Schizophrenia, by Drug/Company, Through 2025
Table 122 : Global Market for Drugs Prescribed to Treat Schizophrenia, by Leading Company, Through 2025
Table 123 : Global Market for Pharmaceutical Excipients, by Material, Through 2026
Table 124 : Global Market for Pharmaceutical Excipients, Through 2026
Table 125 : Global Market for Pharmaceutical Excipients, by Material Type, Through 2026
Table 126 : Global Market for Organic Pharmaceutical Excipients, by Type, Through 2026
Table 127 : Global Market for Carbohydrate Pharmaceutical Excipients, by Type, Through 2026
Table 128 : Global Market for Oleochemical Pharmaceutical Excipients, by Type, Through 2026
Table 129 : Global Market for Petrochemical Pharmaceutical Excipients, by Type, Through 2026
Table 130 : Global Market for Protein Pharmaceutical Excipients, Through 2026
Table 131 : Global Market for Other Organic Pharmaceutical Excipients, Through 2026
Table 132 : Global Market for Inorganic Pharmaceutical Excipients, by Type, Through 2026
Table 133 : Global Market for USP Water in Pharmaceutical Excipients, Through 2026
Table 134 : Global Market for Pharmaceutical Excipients, by Dosage Form, Through 2026
Table 135 : Global Market for Pharmaceutical Excipients, by Route of Administration, Through 2026
Table 136 : Global Market for Pharmaceutical Excipients, by End Users, Through 2026
Table 137 : Global Market Share for Pharmaceutical Companies, 2020
Table 138 : Global Market for Pharmaceutical Excipients, by Region, Through 2026
Table 139 : North American Market for Pharmaceutical Excipients, by Country, Through 2026
Table 140 : European Market for Pharmaceutical Excipients, by Country, Through 2026
Table 141 : Asia-Pacific Market for Pharmaceutical Excipients, by Country, Through 2026
Table 142 : RoW Market for Pharmaceutical Excipients, by Country, Through 2026
Table 143 : Global Market Share Analysis, by Supplier Tier, 2020 and 2026
Table 144 : Examples of Developments in the Pharmaceutical Excipients Industry, 2018-2021
Table 145 : Number of Patents and Patent Applications Worldwide Using Keyword “Excipient,” 2011-2020
Table 146 : Search Analysis for Patents and Patent Applications Worldwide Using Keyword Combinations in Pharmaceutical Excipients
Table 147 : Number of Patents and Patent Applications, by Company
Table 148 : Global Market for Softgel Capsules, by Type, Through 2025
Table 149 : Comparison of Softgel and Hard Capsules
Table 150 : Global Market for Softgel Capsules, by Type, Through 2025
Table 151 : Global Market for Gelatin Softgel Capsules, by Region, Through 2025
Table 152 : Comparison of Vegetarian and Gelatin Capsules
Table 153 : Global Market for Vegetarian Softgel Capsules, by Region, Through 2025
Table 154 : Global Market for Softgel Capsules, by Application, Through 2025
Table 155 : Global Market for Health Supplements in Softgel Capsules, by Region, Through 2025
Table 156 : Global Market for Vitamins and Dietary Supplements in Softgel Capsules, by Region, Through 2025
Table 157 : Global Market for Other Applications in Softgel Capsules, by Region, Through 2025
Table 158 : Global Market for Softgel Capsules, by End User, Through 2025
Table 159 : Global Market for Pharmaceutical and Nutraceuticals Companies in Softgel Capsules, by Region, Through 2025
Table 160 : Global Market for Contract Manufacturing Organizations in Softgel Capsules, by Region, Through 2025
Table 161 : Global Market for Other End Users in Softgel Capsules, Through 2025
Table 162 : Global Market for Softgel Capsules, by Region, Through 2025
Table 163 : North American Market for Softgel Capsules, by Application, Through 2025
Table 164 : North American Market for Softgel Capsules, by Country, Through 2025
Table 165 : European Market for Softgel Capsules, by Application, Through 2025
Table 166 : European Market for Softgel Capsules, by Country, Through 2025
Table 167 : Asia-Pacific Market for Softgel Capsules, by Application, Through 2025
Table 168 : Asia-Pacific Market for Softgel Capsules, by Country, Through 2025
Table 169 : Latin American Market for Softgel Capsules, by Application, Through 2025
Table 170 : Middle Eastern and African Market for Softgel Capsules, by Application, Through 2025
Table 171 : Global Company Ranking in the Market for Softgel Capsules, 2019
Table 172 : Porter’s Five Forces Analysis
Table 173 : Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging, Through 2026
Table 174 : Global Market for Contract Manufacturing of Bulk Drug and APIs, by Region, Through 2026
Table 175 : Global Market for Contract Manufacturing of Various Dosage Forms, by Type, Through 2026
Table 176 : Global Market for Contract Manufacturing of Advanced Drug Delivery Systems, by Region, Through 2026
Table 177 : Global Market for Contract Manufacturing of Advanced Drug Delivery Systems, by Formulation, Through 2026
Table 178 : Global Market for Contract Manufacturing of Over-the-Counter and Nutritional Products, by Region, Through 2026
Table 179 : Global Market for Contract Manufacturing of Over-the-Counter and Nutritional Products, by Formulation, Through 2026
Table 180 : Global Market for Contract Research Services, by Discipline, Through 2026
Table 181 : Global Market for Contract Research Services, by Region, Through 2026
Table 182 : Global Market for Contract Packaging Services, by Type, Through 2026
Table 183 : Global Market for Contract Packaging Services, by Region, Through 2026
Table 184 : Global Market for Contract Manufacturing Drugs, by Application, Through 2026
Table 185 : Global Market for Contract Research Services, by Therapeutic Area, Through 2026
Table 186 : Services Provided by Leading Contract Manufacturing Organizations, 2020
Table 187 : Services Provided by Leading Research Firms, 2020
Table 188 : Services Provided by Leading Contract Packaging Firms, 2020
Table 189 : Historical Developments in the Field of 3D Printing
Table 190 : Pharmaceutical Preparations that Have Been Developed by 3D Printing Technology
Table 191 : Global Market for VR and AR Technologies, by Application, Through 2023
Table 192 : Global Market for VR Technologies, by Component, Through 2023
Table 193 : Global Market for AR Technologies, by Component, Through 2023
Table 194 : Global Market for VR and AR Technologies, by Region, Through 2023
Table 195 : Global Market for IoT in Healthcare, by Solution, Through 2025
Table 196 : Global Market for IoT in Healthcare Medical Devices, by Type, Through 2025
Table 197 : Global Market for IoT in Healthcare, by Application, Through 2025
Table 198 : Global Market for IoT in Healthcare, by End User, Through 2025
Table 199 : Global Market for IoT in Healthcare, by Region, Through 2025
Table 200 : Global Market for Blockchain Technology in Healthcare Applications, Through 2024
Table 201 : Global Market for Blockchain in Healthcare, by Deployment Sector, Through 2024
Table 202 : Global Market for Blockchain in Healthcare, by End User, Through 2024
Table 203 : Global Market for Neurostimulation Devices, by Device Type, Through 2026
Table 204 : Global Market for Neurostimulation Devices, by Device Type, Through 2026
Table 205 : Global Market for Spinal Cord Stimulation (SCS) Devices, by Region, Through 2026
Table 206 : Global Market for Deep Brain Stimulation (DBS) Devices, by Region, Through 2026
Table 207 : Global Market for Sacral Nerve Stimulation (SNS) Devices, by Region, Through 2026
Table 208 : Global Market for Vagus Nerve Stimulation (VNS) Devices, by Region, Through 2026
Table 209 : Global Market for Hypoglossal Nerve Stimulation (HGNS) Devices, by Region, Through 2026
Table 210 : Global Market for Transcutaneous Electrical Nerve Stimulation (TENS) Devices, by Region, Through 2026
Table 211 : Global Market for Transcranial Magnetic Stimulation (TMS) Devices, by Region, Through 2026
Table 212 : Global Market for Other Neurostimulation Devices, by Region, Through 2026
Table 213 : Global Market for Neurostimulation Devices, by Therapeutic Application, Through 2026
Table 214 : Global Market for Neurostimulation Devices, by Region, Through 2026
Table 215 : Global Market Shares of Leading Companies in Spinal Cord Stimulation Devices, 2020
Table 216 : Global Market Shares of Leading Companies in Deep Brain Stimulation Devices, 2020
Table 217 : Global Market Shares of Leading Companies in Sacral Nerve Stimulation Devices, 2020
Table 218 : Global Market Shares of Leading Companies in Vagus Nerve Stimulation Devices, 2020
Table 219 : Global Market Shares of Leading Companies in Hypoglossal Nerve Stimulation Devices, 2020
Table 220 : Global Market Shares of Leading Companies in Transcranial Magnetic Stimulation Devices, 2020
Table 2 : Major Recent and Upcoming Patent Expiries, 2016-2021
Table 3 : Sales of Brand Name Drugs Before and After Patent Expiry
Table 4 : Biologics with Recent or Upcoming Loss of Patent Protection
Table 5 : Global Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 6 : Global Market for Generic Drugs Compared with the Total Pharmaceutical Market, by Region, Through 2025
Table 7 : Global Market for Generic Drugs, by Top 10 Countries, Through 2025
Table 8 : Top 20 Generic Molecules, 2019
Table 9 : Global Top Selling Pharmaceuticals, 2019
Table 10 : Global Market for Generic Drugs, by Region, Through 2025
Table 11 : U.S. Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 12 : Canadian Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 13 : Chinese Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 14 : Japanese Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 15 : Japanese Pharmaceutical Sales, by Top 25 Japanese Pharma Companies, 2018 and 2019
Table 16 : Indian Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 17 : Leading Generic Drug Companies in India
Table 18 : Rest of Asia-Pacific Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 19 : German Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 20 : French Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 21 : Italian Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 22 : U.K. Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 23 : Spanish Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 24 : Penetration of Generic Drugs in the Pharmaceutical Market in the Rest of Europe, by Country, 2019
Table 25 : Rest of European Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 26 : Rest of the World Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
Table 27 : Leading Generic Drug Companies, by Sales, 2019
Table 28 : ANDA Approvals of Generic Drugs, by Company, 2019(Number)
Table 29 : Global Market for Orphan Drugs, by Product Type, Through 2026
Table 30 : Prevalence of Rare Diseases
Table 31 : Comparison of the Regulation of Rare Diseases and Orphan Drugs Worldwide
Table 32 : Global Market for Orphan Drugs, by Product Type, Through 2026
Table 33 : Growth in Orphan Designations, by Region/Country, 2010-2020
Table 34 : Global Market for Orphan Drugs, by Region, Through 2026
Table 35 : Global Orphan Drug Sales, by Drug Type, Through 2026
Table 36 : Global Orphan Drug Sales, by Therapeutic Category, Through 2026
Table 37 : Market Shares of Top 20 Companies, 2020
Table 38 : Characteristics of the NCT, EUCTR and JPRN Trials
Table 39 : Number of Trials in NCT, EUCTR and JPRN Trials, by Phase
Table 40 : Number of Trials in NCT, EUCTR and JPRN Trials, by Country
Table 41 : Top 20 Most Studied Rare Diseases, by Number of Trials
Table 42 : Top 20 Most Studied Drugs for Rare Diseases, by Number of Diseases
Table 43 : Orphan Drug Approvals and Exclusivity, 2020
Table 44 : Global Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 45 : Cancer Drug Treatment Classes
Table 46 : Global Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 47 : Global Market for Targeted Therapy Pharmaceuticals, by Type, Through 2026
Table 48 : Global Market for Immunotherapy Pharmaceuticals, by Type, Through 2026
Table 49 : Global Market for Oncology Pharmaceuticals, by Cancer Type, Through 2026
Table 50 : Global Market for Oncology Pharmaceuticals, by Region, Through 2026
Table 51 : North American Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 52 : European Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 53 : Asia-Pacific Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 54 : RoW Market for Oncology Pharmaceuticals, by Type, Through 2026
Table 55 : Leading Oncology Pharmaceuticals Company's Market Share, 2020
Table 56 : Blockbuster Oncology Pharmaceuticals, 2020
Table 57 : Selected Blockbuster Oncology Pharmaceuticals, by Company, 2020
Table 58 : Global Market for Immunotherapy Drugs, by Product Type, Through 2025
Table 59 : Advantages and Disadvantages of Monoclonal Antibodies
Table 60 : Selected Approved Interferon Alpha Analogs
Table 61 : Biologics as Autoimmune Disorder Therapies
Table 62 : Global Market for Immunotherapy Drugs, by Product Type, Through 2025
Table 63 : Global Market for Monoclonal Antibodies, by Type, Through 2025
Table 64 : Global Market Shares for Monoclonal Antibody Drugs, by Type, 2019
Table 65 : Global Market for Monoclonal Antibody Drugs, by Region, Through 2025
Table 66 : Global Market for Checkpoint Inhibitors, 2019-2025
Table 67 : Global Market of Checkpoint Inhibitors, by Region, Through 2025
Table 68 : Global Market for Interferons and Interleukins, Through 2025
Table 69 : Global Market for Interferons and Interleukins, by Region, Through 2025
Table 70 : Global Market for Infectious Disease Treatments, by Segment, Through 2026
Table 71 : Leading Causes of Death Due to Infectious Diseases, by Region, 2019
Table 72 : Global Market for Infectious Disease Treatment, by Region, Through 2026
Table 73 : Global Market for Infectious Disease Treatments, by Segment, Through 2026
Table 74 : Global Market for Infectious Disease Therapeutics, by Disease Type, Through 2026
Table 75 : Global Market for Infectious Disease Vaccines, by Disease Type, Through 2026
Table 76 : Global Market for Infectious Disease Diagnostics, by Disease Type, Through 2026
Table 77 : Global Market for Hepatitis B Therapeutics, by Region, Through 2026
Table 78 : Global Market for Hepatitis B Vaccines, by Region, Through 2026
Table 79 : Global Market for Hepatitis B Diagnostics, by Region, Through 2026
Table 80 : Global Market for Hepatitis C Therapeutics, by Region, Through 2026
Table 81 : Global Market for Hepatitis C Diagnostics, by Region, Through 2026
Table 82 : Global Market for HSV Therapeutics, by Region, Through 2026
Table 83 : Global Market for HSV Diagnostics, by Region, Through 2026
Table 84 : Global Market for HIV Therapeutics, by Region, Through 2026
Table 85 : Global Market for HIV Diagnostics, by Region, Through 2026
Table 86 : Global Market for Influenza Vaccines, by Region, Through 2026
Table 87 : Global Market for Influenza Diagnostics, by Region, Through 2026
Table 88 : Global Market for Rotavirus Vaccines, by Region, Through 2026
Table 89 : Global Market for Rotavirus Diagnostics, by Region, Through 2026
Table 90 : Global Market for RSV Vaccines, by Region, Through 2026
Table 91 : Global Market for RSV Diagnostics, by Region, Through 2026
Table 92 : Global Market for Malaria Therapeutics, by Region, Through 2026
Table 93 : Global Market for Malaria Vaccines, by Region, Through 2026
Table 94 : Global Market for Malaria Diagnostics (RDTs*), by Region, Through 2026
Table 95 : Global Market for Tuberculosis Therapeutics, by Region, Through 2026
Table 96 : Global Market for Tuberculosis Diagnostics, by Region, Through 2026
Table 97 : Global Market for MERS-CoV Vaccines, by Region, Through 2026
Table 98 : Global Market for Lassa Fever Vaccines, by Region, Through 2026
Table 99 : Global Market for Ebola Fever Vaccines, Through 2026
Table 100 : Global Market for Zika Vaccines, by WHO Region, Through 2026
Table 101 : Global Market for Yellow Fever Vaccines, by WHO Region, Through 2026
Table 102 : Global Market for Dengue Vaccines, by Region, Through 2026
Table 103 : Global Market for Drugs Prescribed to Treat Mental Health Disorders, by Type of Disorder, Through 2025
Table 104 : Global Market for Drugs Prescribed to Treat ADHD, Through 2025
Table 105 : Global Market for Drugs Prescribed to Treat ADHD, by Region, Through 2025
Table 106 : Global Market for Leading Brand Name Drugs Prescribed to Treat ADHD, by Drug/Company, Through 2025
Table 107 : Global Market for Drugs Prescribed to Treat ADHD, by Leading Company/Manufacturer, Through 2025
Table 108 : Drug Profiles of Leading Approved ADHD Treatments
Table 109 : ADHD Drug Profiles
Table 110 : Global Market for Drugs Prescribed to Treat Depression and Anxiety, Through 2025
Table 111 : Global Market for Brand Name Drugs Prescribed to Treat Depression and Anxiety, by Leading Drug/Company, Through 2025
Table 112 : Global Market for Drugs Prescribed to Treat Depression and Anxiety, by Leading Company/Manufacturer
Table 113 : Drug Profiles of Leading Approved Antidepressants
Table 114 : Drugs Recommended for the Treatment of Anxiety
Table 115 : Global Market for Drugs Prescribed to Treat Substance Use Disorders, Through 2025
Table 116 : Global Market for Drugs Prescribed to Treat Substance Use Disorders, by Region, Through 2025
Table 117 : Global Market for Leading Brand Name Drugs Prescribed to Treat Substance Use Disorders, by Drug/Company, Through 2025
Table 118 : Global Market for Drugs Prescribed to Treat Substance Use Disorders, by Leading Company, Through 2025
Table 119 : Global Market for Drugs Prescribed to Treat Schizophrenia, Through 2025
Table 120 : Global Market for Drugs Prescribed to Treat Schizophrenia, by Region, Through 2025
Table 121 : Global Market for Leading Brand Name Drugs Prescribed to Treat Schizophrenia, by Drug/Company, Through 2025
Table 122 : Global Market for Drugs Prescribed to Treat Schizophrenia, by Leading Company, Through 2025
Table 123 : Global Market for Pharmaceutical Excipients, by Material, Through 2026
Table 124 : Global Market for Pharmaceutical Excipients, Through 2026
Table 125 : Global Market for Pharmaceutical Excipients, by Material Type, Through 2026
Table 126 : Global Market for Organic Pharmaceutical Excipients, by Type, Through 2026
Table 127 : Global Market for Carbohydrate Pharmaceutical Excipients, by Type, Through 2026
Table 128 : Global Market for Oleochemical Pharmaceutical Excipients, by Type, Through 2026
Table 129 : Global Market for Petrochemical Pharmaceutical Excipients, by Type, Through 2026
Table 130 : Global Market for Protein Pharmaceutical Excipients, Through 2026
Table 131 : Global Market for Other Organic Pharmaceutical Excipients, Through 2026
Table 132 : Global Market for Inorganic Pharmaceutical Excipients, by Type, Through 2026
Table 133 : Global Market for USP Water in Pharmaceutical Excipients, Through 2026
Table 134 : Global Market for Pharmaceutical Excipients, by Dosage Form, Through 2026
Table 135 : Global Market for Pharmaceutical Excipients, by Route of Administration, Through 2026
Table 136 : Global Market for Pharmaceutical Excipients, by End Users, Through 2026
Table 137 : Global Market Share for Pharmaceutical Companies, 2020
Table 138 : Global Market for Pharmaceutical Excipients, by Region, Through 2026
Table 139 : North American Market for Pharmaceutical Excipients, by Country, Through 2026
Table 140 : European Market for Pharmaceutical Excipients, by Country, Through 2026
Table 141 : Asia-Pacific Market for Pharmaceutical Excipients, by Country, Through 2026
Table 142 : RoW Market for Pharmaceutical Excipients, by Country, Through 2026
Table 143 : Global Market Share Analysis, by Supplier Tier, 2020 and 2026
Table 144 : Examples of Developments in the Pharmaceutical Excipients Industry, 2018-2021
Table 145 : Number of Patents and Patent Applications Worldwide Using Keyword “Excipient,” 2011-2020
Table 146 : Search Analysis for Patents and Patent Applications Worldwide Using Keyword Combinations in Pharmaceutical Excipients
Table 147 : Number of Patents and Patent Applications, by Company
Table 148 : Global Market for Softgel Capsules, by Type, Through 2025
Table 149 : Comparison of Softgel and Hard Capsules
Table 150 : Global Market for Softgel Capsules, by Type, Through 2025
Table 151 : Global Market for Gelatin Softgel Capsules, by Region, Through 2025
Table 152 : Comparison of Vegetarian and Gelatin Capsules
Table 153 : Global Market for Vegetarian Softgel Capsules, by Region, Through 2025
Table 154 : Global Market for Softgel Capsules, by Application, Through 2025
Table 155 : Global Market for Health Supplements in Softgel Capsules, by Region, Through 2025
Table 156 : Global Market for Vitamins and Dietary Supplements in Softgel Capsules, by Region, Through 2025
Table 157 : Global Market for Other Applications in Softgel Capsules, by Region, Through 2025
Table 158 : Global Market for Softgel Capsules, by End User, Through 2025
Table 159 : Global Market for Pharmaceutical and Nutraceuticals Companies in Softgel Capsules, by Region, Through 2025
Table 160 : Global Market for Contract Manufacturing Organizations in Softgel Capsules, by Region, Through 2025
Table 161 : Global Market for Other End Users in Softgel Capsules, Through 2025
Table 162 : Global Market for Softgel Capsules, by Region, Through 2025
Table 163 : North American Market for Softgel Capsules, by Application, Through 2025
Table 164 : North American Market for Softgel Capsules, by Country, Through 2025
Table 165 : European Market for Softgel Capsules, by Application, Through 2025
Table 166 : European Market for Softgel Capsules, by Country, Through 2025
Table 167 : Asia-Pacific Market for Softgel Capsules, by Application, Through 2025
Table 168 : Asia-Pacific Market for Softgel Capsules, by Country, Through 2025
Table 169 : Latin American Market for Softgel Capsules, by Application, Through 2025
Table 170 : Middle Eastern and African Market for Softgel Capsules, by Application, Through 2025
Table 171 : Global Company Ranking in the Market for Softgel Capsules, 2019
Table 172 : Porter’s Five Forces Analysis
Table 173 : Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging, Through 2026
Table 174 : Global Market for Contract Manufacturing of Bulk Drug and APIs, by Region, Through 2026
Table 175 : Global Market for Contract Manufacturing of Various Dosage Forms, by Type, Through 2026
Table 176 : Global Market for Contract Manufacturing of Advanced Drug Delivery Systems, by Region, Through 2026
Table 177 : Global Market for Contract Manufacturing of Advanced Drug Delivery Systems, by Formulation, Through 2026
Table 178 : Global Market for Contract Manufacturing of Over-the-Counter and Nutritional Products, by Region, Through 2026
Table 179 : Global Market for Contract Manufacturing of Over-the-Counter and Nutritional Products, by Formulation, Through 2026
Table 180 : Global Market for Contract Research Services, by Discipline, Through 2026
Table 181 : Global Market for Contract Research Services, by Region, Through 2026
Table 182 : Global Market for Contract Packaging Services, by Type, Through 2026
Table 183 : Global Market for Contract Packaging Services, by Region, Through 2026
Table 184 : Global Market for Contract Manufacturing Drugs, by Application, Through 2026
Table 185 : Global Market for Contract Research Services, by Therapeutic Area, Through 2026
Table 186 : Services Provided by Leading Contract Manufacturing Organizations, 2020
Table 187 : Services Provided by Leading Research Firms, 2020
Table 188 : Services Provided by Leading Contract Packaging Firms, 2020
Table 189 : Historical Developments in the Field of 3D Printing
Table 190 : Pharmaceutical Preparations that Have Been Developed by 3D Printing Technology
Table 191 : Global Market for VR and AR Technologies, by Application, Through 2023
Table 192 : Global Market for VR Technologies, by Component, Through 2023
Table 193 : Global Market for AR Technologies, by Component, Through 2023
Table 194 : Global Market for VR and AR Technologies, by Region, Through 2023
Table 195 : Global Market for IoT in Healthcare, by Solution, Through 2025
Table 196 : Global Market for IoT in Healthcare Medical Devices, by Type, Through 2025
Table 197 : Global Market for IoT in Healthcare, by Application, Through 2025
Table 198 : Global Market for IoT in Healthcare, by End User, Through 2025
Table 199 : Global Market for IoT in Healthcare, by Region, Through 2025
Table 200 : Global Market for Blockchain Technology in Healthcare Applications, Through 2024
Table 201 : Global Market for Blockchain in Healthcare, by Deployment Sector, Through 2024
Table 202 : Global Market for Blockchain in Healthcare, by End User, Through 2024
Table 203 : Global Market for Neurostimulation Devices, by Device Type, Through 2026
Table 204 : Global Market for Neurostimulation Devices, by Device Type, Through 2026
Table 205 : Global Market for Spinal Cord Stimulation (SCS) Devices, by Region, Through 2026
Table 206 : Global Market for Deep Brain Stimulation (DBS) Devices, by Region, Through 2026
Table 207 : Global Market for Sacral Nerve Stimulation (SNS) Devices, by Region, Through 2026
Table 208 : Global Market for Vagus Nerve Stimulation (VNS) Devices, by Region, Through 2026
Table 209 : Global Market for Hypoglossal Nerve Stimulation (HGNS) Devices, by Region, Through 2026
Table 210 : Global Market for Transcutaneous Electrical Nerve Stimulation (TENS) Devices, by Region, Through 2026
Table 211 : Global Market for Transcranial Magnetic Stimulation (TMS) Devices, by Region, Through 2026
Table 212 : Global Market for Other Neurostimulation Devices, by Region, Through 2026
Table 213 : Global Market for Neurostimulation Devices, by Therapeutic Application, Through 2026
Table 214 : Global Market for Neurostimulation Devices, by Region, Through 2026
Table 215 : Global Market Shares of Leading Companies in Spinal Cord Stimulation Devices, 2020
Table 216 : Global Market Shares of Leading Companies in Deep Brain Stimulation Devices, 2020
Table 217 : Global Market Shares of Leading Companies in Sacral Nerve Stimulation Devices, 2020
Table 218 : Global Market Shares of Leading Companies in Vagus Nerve Stimulation Devices, 2020
Table 219 : Global Market Shares of Leading Companies in Hypoglossal Nerve Stimulation Devices, 2020
Table 220 : Global Market Shares of Leading Companies in Transcranial Magnetic Stimulation Devices, 2020
List of Figures
Figure 1 : Global Market for Generic Drugs, by Region, 2018-2025
Figure 2 : Trends in Global Prescription Drug Sales, 2015-2019
Figure 3 : Global Market Shares of Pharmaceutical Drugs, by Therapeutic Area, 2019
Figure 4 : Global Market for Generic Drugs, by Region, 2018-2025
Figure 5 : Global Market for Orphan Drugs, by Product Type, 2020-2026
Figure 6 : Comparison of the Three Registries (NCT, EUCTR, and JPRN), by Number of Trials
Figure 7 : Comparison of the Three Registries (NCT, EUCTR, and JPRN), by Number of Diseases
Figure 8 : Comparison of the Three Registries (NCT, EUCTR, and JPRN), by Number of Drugs
Figure 9 : Global Market for Oncology Pharmaceuticals, by Type, 2020-2026
Figure 10 : Global Market for Immunotherapy Drugs, by Product Type, 2019-2025
Figure 11 : Potential Targets for Checkpoint Inhibition in Clinical Evaluation
Figure 12 : Global Market for Pembrolizumab, 2019-2025
Figure 13 : Global Market for Nivolumab, 2019-2025
Figure 14 : Global Market for Atezolizumab, 2019-2025
Figure 15 : Global Market for Avelumab, 2019-2025
Figure 16 : Global Market for Durvalumab, 2019-2025
Figure 17 : Global Market for Ipilimumab, 2019-2025
Figure 18 : SWOT Analysis of Immunotherapy Market
Figure 19 : Global Market for Infectious Disease Treatments, by Segment, 2020-2026
Figure 20 : Leading Causes of Death Due to Infectious Diseases, by Region, 2019
Figure 21 : Global Market for Drugs Prescribed to Treat Mental Health Disorders, by Type of Disorder, 2019-2025
Figure 22 : Global Market for Pharmaceutical Excipients, by Material, 2020-2026
Figure 23 : Classification of Pharmaceutical Excipient
Figure 24 : Pharmaceutical Excipients: Market Dynamics
Figure 25 : Organic Pharmaceutical Excipients Market Categories
Figure 26 : Tier-based Positioning of Pharmaceutical Excipients Manufacturers/Suppliers, 2021
Figure 27 : Global Market Shares of Softgel Capsules, by Type, 2019
Figure 28 : Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging, 2020-2026
Figure 29 : Global Market Shares of Contract Manufacturing Services, by Top 22 Companies, 2020
Figure 30 : Global Market Shares of Contract Research Services, by Top Companies, 2020
Figure 31 : Global Market Shares of Contract Packaging Services, by Top Companies, 2020
Figure 32 : Global Market Shares of Neurostimulation Devices, by Device Type, 2020
Figure 2 : Trends in Global Prescription Drug Sales, 2015-2019
Figure 3 : Global Market Shares of Pharmaceutical Drugs, by Therapeutic Area, 2019
Figure 4 : Global Market for Generic Drugs, by Region, 2018-2025
Figure 5 : Global Market for Orphan Drugs, by Product Type, 2020-2026
Figure 6 : Comparison of the Three Registries (NCT, EUCTR, and JPRN), by Number of Trials
Figure 7 : Comparison of the Three Registries (NCT, EUCTR, and JPRN), by Number of Diseases
Figure 8 : Comparison of the Three Registries (NCT, EUCTR, and JPRN), by Number of Drugs
Figure 9 : Global Market for Oncology Pharmaceuticals, by Type, 2020-2026
Figure 10 : Global Market for Immunotherapy Drugs, by Product Type, 2019-2025
Figure 11 : Potential Targets for Checkpoint Inhibition in Clinical Evaluation
Figure 12 : Global Market for Pembrolizumab, 2019-2025
Figure 13 : Global Market for Nivolumab, 2019-2025
Figure 14 : Global Market for Atezolizumab, 2019-2025
Figure 15 : Global Market for Avelumab, 2019-2025
Figure 16 : Global Market for Durvalumab, 2019-2025
Figure 17 : Global Market for Ipilimumab, 2019-2025
Figure 18 : SWOT Analysis of Immunotherapy Market
Figure 19 : Global Market for Infectious Disease Treatments, by Segment, 2020-2026
Figure 20 : Leading Causes of Death Due to Infectious Diseases, by Region, 2019
Figure 21 : Global Market for Drugs Prescribed to Treat Mental Health Disorders, by Type of Disorder, 2019-2025
Figure 22 : Global Market for Pharmaceutical Excipients, by Material, 2020-2026
Figure 23 : Classification of Pharmaceutical Excipient
Figure 24 : Pharmaceutical Excipients: Market Dynamics
Figure 25 : Organic Pharmaceutical Excipients Market Categories
Figure 26 : Tier-based Positioning of Pharmaceutical Excipients Manufacturers/Suppliers, 2021
Figure 27 : Global Market Shares of Softgel Capsules, by Type, 2019
Figure 28 : Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging, 2020-2026
Figure 29 : Global Market Shares of Contract Manufacturing Services, by Top 22 Companies, 2020
Figure 30 : Global Market Shares of Contract Research Services, by Top Companies, 2020
Figure 31 : Global Market Shares of Contract Packaging Services, by Top Companies, 2020
Figure 32 : Global Market Shares of Neurostimulation Devices, by Device Type, 2020
